Jeffrey Scott Kitchell - 17 Nov 2025 Form 3 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Signature
/s/ Jeffrey Scott Kitchell
Issuer symbol
PURE
Transactions as of
17 Nov 2025
Transactions value $
$0
Form type
3
Filing time
28 Nov 2025, 18:25:08 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kitchell Jeffrey Scott President, Corporate Secretary 771 JAMACHA RD., #512, EL CAJON /s/ Jeffrey Scott Kitchell 28 Nov 2025 0002098340

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PURE Common Stock 13K 17 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PURE Stock Options (Right to Buy) 17 Nov 2025 Common Stock 45K $0.33 Direct F1
holding PURE Stock Options (Right to Buy) 17 Nov 2025 Common Stock 45K $0.79 Direct F2
holding PURE Stock Options (Right to Buy) 17 Nov 2025 Common Stock 70K $0.45 Direct F3
holding PURE Stock Options (Right to Buy) 17 Nov 2025 Common Stock 90K $0.20 Direct F4
holding PURE Stock Options (Right to Buy) 17 Nov 2025 Common Stock 150K $0.12 Direct F5
holding PURE Stock Options (Right to Buy) 17 Nov 2025 Common Stock 155K $0.07 Direct F6
holding PURE Stock Options (Right to Buy) 17 Nov 2025 Common Stock 300K $0.07 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 29, 2020 and became fully vested on January 29, 2021.
F2 The option was granted on May 15, 2020 and became fully vested on May 15, 2021.
F3 The option was granted on June 18, 2021 and became fully vested on June 18, 2022.
F4 The option was granted on September 30, 2022 and became fully vested on September 30, 2023.
F5 The option was granted on August 1, 2023 and became fully vested on August 1, 2024.
F6 The option was granted on August 20, 2024 and became fully vested on August 20, 2025.
F7 The option was granted on September 23, 2025. The option shares shall vest and become exercisable in four equal installments on December 23, 2025, March 23, 2026, June 23, 2026, and September 23, 2026.